淼淼Elva

Paper Talk

Sharing research articles, tracking the latest developments

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: www.xiaoyuzhoufm.com

Autor

淼淼Elva

Kategoria

Science

Strona podcastu

www.xiaoyuzhoufm.com

Ostatni odcinek

16 paź 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Pobierz z Google Play Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

1281-hiPS Cell Model for Holistic Study of EMT Transitions 15.07.2026

This research introduces a robust experimental framework using human induced pluripotent stem (hiPS) cells to standardize the study of the epithelial-to-mesenchymal transition (EMT) . By utilizing both two-dimensional colonies and three-dimensional lumenoids, the authors provide a multimodal platform to observe functional, molecular, and organizational changes in a controlled environment. The stud...

1280-Tumor Heterogeneity in Hepatocellular Carcinoma 14.07.2026

This research utilizes single-cell RNA sequencing and machine learning to map the complex cellular landscape of hepatocellular carcinoma (HCC) . The authors identified five distinct malignant cell subpopulations, discovering that specific clusters associated with advanced-stage tumors drive progression through unique signaling pathways and metabolic shifts. A central finding highlights PGAM2 as a...

1279-Noninvasive Phenotyping for Liver Cancer Prognosis 14.07.2026

This study introduces MTV-Net , a novel artificial intelligence framework designed to analyze the vascular microenvironment of primary liver cancers through routine CT scans . By extracting quantitative vascular features , the researchers developed two noninvasive biomarkers that accurately identify tumor subtypes and predict post-surgical recurrence risk. This multi-task learning approach proved...

1278-Multi-Omics for Pulmonary Adenocarcinoma Grading 14.07.2026

This study introduces a bio-interpretable ensemble learning model designed to accurately categorize the severity of invasive pulmonary adenocarcinoma (IPA) . By integrating computed tomography (CT) scans with whole slide pathology images , the researchers developed a multimodal tool that identifies high-grade tumors more reliably than traditional manual assessments. Beyond mere prediction, the pro...

1277-SLC Transporters in Cancer Metabolism 14.07.2026

The Solute Carrier (SLC) transporter family, a vast group of over 450 proteins, serves as the primary gateway for moving essential nutrients like glucose, amino acids, and lipids across cell membranes. While these proteins maintain healthy metabolic balance in normal tissues, they are frequently hijacked by cancer cells to fuel rapid growth and resist medical treatment. Key transporters such as GL...

1276-Models for Drug-Drug Interaction Prediction 14.07.2026

This paper provides a comprehensive analysis of machine learning (ML) and artificial intelligence (AI) methodologies used to predict drug-drug interactions (DDIs) . It explains that traditional experimental methods for identifying these interactions are often too slow and expensive to keep pace with modern pharmacology. To solve this, researchers utilize biomedical databases and computational mode...

1275-Predicting Anticancer Drug Interactions 13.07.2026

This systematic review examines the implementation of machine learning and deep learning architectures to predict drug-drug interactions specifically involving anticancer medications . Because oncology patients frequently require polypharmacy , they face a heightened risk of adverse events or reduced treatment efficacy caused by complex biochemical interferences. The researchers analyzed 59 studie...

1274-IMIREG: Regulon Signature of Immunotherapy Response 13.07.2026

Researchers have developed IMIREG , a novel 14-regulon transcriptional signature designed to predict how patients with various cancers will respond to immune checkpoint blockade (ICB) . By utilizing a systems-biology approach to infer the activity of master transcription factors , this biomarker moves beyond simple immune cell counts to capture the actual regulatory circuitry of the tumor microenv...

1273-GZMK+ T Cells as Biomarkers for Immunotherapy Response 13.07.2026

This research identifies granzyme K (GZMK) expression in T cells as a critical biomarker for predicting success in neoadjuvant cancer immunotherapies. By analyzing single-cell data from head and neck cancer patients, the study reveals that GZMK+ progenitor T cells recently recruited from the blood represent a state of high antitumor immunocompetence . Successful treatment outcomes are strongly lin...

1272-Mapping Invasive-Front Signature of Bladder Cancer 13.07.2026

This article details a spatial transcriptomic study of non-muscle-invasive bladder cancer using high-quality en bloc resection specimens. By preserving the three-dimensional architecture of the tissue, researchers identified a distinct 15-gene signature specifically enriched at the tumor-boundary region , or invasive front. These genes are primarily associated with epithelial-mesenchymal transitio...

1271-AI for Rational Polypharmacology drug design 13.07.2026

This review examines the shift from traditional single-target therapies toward rational polypharmacology through the integration of artificial intelligence and network biology . By conceptualizing diseases as failures within complex signaling webs rather than isolated malfunctions, researchers use machine learning and graph neural networks to identify multi-target intervention sites that circumven...

1270-SQLE as a Diagnostic and Prognostic Biomarker for LIHC 12.07.2026

This research identifies Squalene epoxidase (SQLE) as a significant diagnostic and prognostic biomarker for liver hepatocellular carcinoma (LIHC) . Through extensive bioinformatics across multiple datasets and clinical tissue validation, the study reveals that SQLE is consistently overexpressed in cancerous liver tissues and correlates with advanced disease stages and poor survival rates. Function...

1269-Blood Proteomic Signatures of NSCLC Surgical 12.07.2026

This study investigates the use of blood proteomics to identify non-invasive biomarkers for non-small cell lung cancer (NSCLC) . Researchers utilized the SomaScan and NULISA platforms to analyze protein signatures in patients undergoing surgery or immunotherapy . The findings highlight specific proteins, such as MUC16 and IL-6 , which can predict tumor recurrence , treatment response, and overall...

1268-Deep Learning Biomarkers for Gastric Cancer Prognosis 12.07.2026

Researchers have developed a Transformer-based deep learning framework to create an interpretable pathological risk score (TPRS) for gastric cancer patients. This AI model analyzes routine whole-slide images to improve survival predictions beyond the capabilities of the traditional TNM staging system . Validated on both internal and external datasets, the tool acts as an independent prognostic bio...

1267-STIL as a Key Driver of Li-Fraumeni Syndrome 12.07.2026

Through a combination of multi-omics analysis and in vitro experiments , this study identifies STIL as a critical molecular link between Li-Fraumeni syndrome and osteosarcoma . The research reveals that STIL functions as a negative regulator of p53 stability , promoting tumor growth and maintaining cancer stemness regardless of the patient's specific TP53 mutation status. Using single-cell sequenc...

1266-CBX2 Phase Regulates EV Biogenesis in tumor Metastasis 12.07.2026

This study identifies the protein CBX2 as a critical driver of omental metastasis in ovarian carcinoma by enhancing the production of pro-metastatic extracellular vesicles . The researchers demonstrate that CBX2 utilizes liquid-liquid phase separation to transcriptionally upregulate FLOT1 , which subsequently triggers the remodeling of lipid rafts on cell membranes. These remodeled microdomains fa...

1265-VDAC2 Pan-Cancer Analysis: Decoding Tumor Evolution 11.07.2026

The paper details a comprehensive multi-omics and pan-cancer study investigating the role of VDAC2 , a mitochondrial protein, in tumor development and immune system evasion. Researchers utilized machine learning, spatial transcriptomics, and laboratory experiments to demonstrate that VDAC2 is significantly overexpressed in most solid tumors, where it promotes cell proliferation, metabolic shifts,...

1264-Prostate Cancer Neuroendocrine Differentiation 11.07.2026

This manuscript examines the emergence of neuroendocrine differentiation (NED) during the early stages of prostate cancer progression. By utilizing spatial transcriptomics and single-cell RNA sequencing , researchers identified a distinct molecular subtype in hormone-sensitive tissues that predicts a poor clinical prognosis . The study established a six-gene biomarker panel —comprising FMN2, APLP1...

1263-AI-Driven Body Composition Atlas in NSCLC 11.07.2026

The paper details a large-scale multicenter study that utilized deep learning to analyze how body composition affects treatment outcomes for patients with non-small cell lung cancer receiving immunotherapy . Researchers developed an AI-driven pipeline to extract nearly 100 parameters from CT scans, discovering that specific fat and muscle distributions are significant independent predictors of sur...

1262-Deep Learning Pathomics Signature for Gastric Cancer 11.07.2026

This multi-center study introduces a pathomics signature for gastric cancer (PSGC) , which utilizes deep learning to analyze standard H&E-stained tissue slides. Researchers developed this artificial intelligence model to overcome the limitations of traditional staging systems, providing a more accurate method for predicting patient survival and treatment response . The study found that patient...

1261-MARCKS Reprograms Immunosuppressive Microenvironment 11.07.2026

This research identifies MARCKS as a critical driver of hepatocellular carcinoma (HCC) progression by reprogramming the tumor immune microenvironment . Utilizing multi-omics analysis , the study demonstrates that elevated MARCKS expression correlates with aggressive clinical features and poor patient outcomes. The protein is primarily enriched in myeloid cells , where it facilitates the transition...

1260-Prostate Cancer: Genomic Landscape & Precision Therapy 10.07.2026

This paper provides a comprehensive analysis of the genomic landscape and precision medicine strategies currently reshaping prostate cancer management. The text highlights how molecular profiling has identified critical drivers of disease progression, such as androgen receptor signaling, DNA damage repair mutations, and lineage plasticity. These biological insights are enabling the transition from...

1259-Overcoming Midostaurin Resistance in AML 10.07.2026

This study investigates the molecular and phenotypic mechanisms behind midostaurin resistance in FLT3-mutated acute myeloid leukemia (AML). Researchers identified a specific progenitor-like cell population marked by CD45RA and CD38 expression that facilitates survival through a signaling shift from STAT5 to PI3K/AKT. Using multi-omic profiling and functional drug testing, the authors discovered th...

1258-Cellular Differentiation Trajectories in Gastric Antrum 10.07.2026

This study utilizes single-cell RNA profiling and spatial transcriptomics to map how epithelial cells transform during the progression of intestinal-type gastric cancer. By examining stages from chronic inflammation to early malignancy, researchers identified that progenitor cells (PCs) serve as the primary source for various cell lineages in the gastric antrum. During intestinal metaplasia, both...

1257-AI-Driven Nanoplatforms for Targeted Ovarian Cancer 10.07.2026

Recent research focuses on overcoming the high mortality and treatment resistance of ovarian cancer by targeting its immunosuppressive tumor microenvironment. Scientists are utilizing single-cell and spatial omics technologies to map the precise location of "exclusion structures" where immune cells like Tregs and TAMs congregate in hypoxic regions to block therapy. These detailed spatial atlases g...

Słuchaj podcastu Paper Talk w Replaio

Radio i podcasty w jednej aplikacji - za darmo, bez zakładania konta. Zainstaluj już dziś i nie przegap premiery

Pobierz z Google Play

Replaio nie jest wydawcą podcastów; nazwy audycji, okładki i audio należą do ich autorów i są rozpowszechniane przez publiczne kanały RSS